Your browser doesn't support javascript.
loading
Pharmacokinetic Evaluation of Darunavir Administered Once or Twice Daily in Combination with Ritonavir or the Three-Direct-Acting Antiviral Regimen of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults Coinfected with Hepatitis C and Human Immunodeficiency Viruses.
King, Jennifer R; Khatri, Amit; Trinh, Roger; Viani, Rolando M; Ding, Bifeng; Zha, Jiuhong; Menon, Rajeev.
Afiliação
  • King JR; AbbVie Inc., Clinical Pharmacology and Pharmacometrics, North Chicago, Ilinois, USA.
  • Khatri A; AbbVie Inc., Clinical Pharmacology and Pharmacometrics, North Chicago, Ilinois, USA.
  • Trinh R; AbbVie Inc., Infectious Disease Development, North Chicago, Ilinois, USA.
  • Viani RM; AbbVie Inc., Infectious Disease Development, North Chicago, Ilinois, USA.
  • Ding B; AbbVie Inc., Biometrics, North Chicago, Ilinois, USA.
  • Zha J; AbbVie Inc., Clinical Pharmacology and Pharmacometrics, North Chicago, Ilinois, USA.
  • Menon R; AbbVie Inc., Clinical Pharmacology and Pharmacometrics, North Chicago, Ilinois, USA Rajeev.menon@abbvie.com.
Article em En | MEDLINE | ID: mdl-27919899

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Sulfonamidas / Uracila / Carbamatos / Ritonavir / Compostos Macrocíclicos / Darunavir / Anilidas Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Sulfonamidas / Uracila / Carbamatos / Ritonavir / Compostos Macrocíclicos / Darunavir / Anilidas Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article